In a recent interview, Ibrahim Danad, M.D., Ph.D., discussed new research findings from the multicenter CONFIRM2 trial and use of the AI-CT software to obtain automated quantification of plaque burden based off coronary computed tomography angiography (CCTA) scans.
The latest update of the Cardiovascular Workspace software reportedly emphasizes secure cloud deployment and accelerated adoption of AI tools for increased efficiency.
Use of AI provided a pooled 22 percent increase in adenoma detection but no significant impact for advanced adenomas, according to an analysis of 39 randomized controlled trials examining AI’s impact in detecting colorectal cancer.
Multivariable analysis from a new study revealed that those with low right ventricular global longitudinal strain were 16 percent more likely to suffer heart failure.
The launch of the AVI imaging platform reportedly facilitates direct integration into PACS and RS systems, and automated access to adjunctive CT-based AI applications for a variety of conditions including pulmonary embolism, intracranial hemorrhage and large vessel occlusion
Offering a “safety net” in emergency and inpatient settings, the Chest CT software reportedly provides enhanced triage capabilities and adjunctive detection of 167 radiological features.
In a recent interview, Timothy Fairbairn, Ph.D., and Fatima Rodiguez, M.D., discussed new research findings, recently presented at the American Heart Association (AHA) conference, showing the value of AI-powered quantification of plaque burden from CCTA exams for predicting adverse cardiovascular outcomes.
Fan reaction to significant defeats of a soccer team was linked to lower activation of the dorsal anterior cingulate cortex and deactivation of the salience network, which may lead to changes with emotional regulation and cognitive control, according to new brain MRI research.
In a prospective study comparing PSMA PET/CT and mpMRI for biopsy- and imaging-naïve men with suspected prostate cancer (PCa), PSMA PET/CT led to altered management in 34 percent of confirmed cases of PCa.
There are no modifications to the order when it comes to CMS and insurance company criteria for reimbursement.
Catch up on the top radiology content of the past week.
In a recent interview, Hari Kishan Gonuguntla, M.D., discussed AI-powered evaluation of chest X-rays with the Lung Nodule Malignancy Score software and key findings from multinational prospective research presented at the recent ESMO Congress 2025 meeting.
New research shows that incorporating the CT vascular sign into assessments of pulmonary nodules led to significant increases in specificity and accuracy as well as reduced false positive rates for differentiating between malignant and benign solid pulmonary nodules.
In the second part of a recent interview on new molecular imaging guidelines for renal masses, Steven Rowe, M.D., discussed the off-label utility of the mitochondrial imaging agent 99mTc-sestamibi and the potential role of AI in advanced imaging for indeterminate renal masses.
In a new review from the European Society of Urogenital Radiology (ESUR), researchers discuss the merits and limitations of PSMA PET/CT and whole-body MRI (WB-MRI) for patients with advanced prostate cancer.
Researchers found no statistically significant differences between bpMRI and mpMRI evaluations of patients with PI-RADS 3 presentations, according to a new multi-reader study.
The Harrison.ai Open Platform reportedly emphasizes open architecture, customer ROI and elimination of costly AI platform fees.
The Sonosite MT ultrasound device reportedly combines portability and enhanced high-resolution images with multiple features to promote workflow efficiency.
Contrast-enhanced mammography demonstrated a 95 percent specificity rate and 83.5 percent positive predictive value for ascertaining pathologic nipple involvement, according to a new multicenter study.
In a recent interview, Steven Rowe, M.D., discussed pertinent insights from recently published molecular imaging guidelines for renal masses and the potential of 89Zr-girentuximab for clear cell renal cell carcinoma (ccRCC).
Ultrasound-derived fat fraction assessment offered higher AUCs for differentiating mild, moderate and severe hepatic steatosis in comparison to established noninvasive measures of metabolic dysfunction-associated steatosis liver disease (MASLD), according to new multicenter research.
Already in use in multiple countries, the Pulsenmore ES ultrasound platform reportedly enables expectant mothers to transmit ultrasound video clips through a smartphone app for remote interpretation.
One can rail about the forces that resulted in an undesirable status quo direction or take a more active role in grabbing the steering wheel.
Catch up on the top radiology content of the past week.
Radiologists from closed practices were 10 percent more likely to practice as subspecialists the following year, according to a newly published analysis.
Expanded capabilities for the Sirona Advanced Imaging Suite reportedly include quantitative SUV analysis and multiplanar reconstruction for PET/CT imaging.
Catch up on the most-well viewed prostate cancer imaging content in October 2025.
Catch up on the most well-viewed breast imaging content in October 2025.
The AI-powered cvi42 | Plaque software enables adjunctive on-site interpretation of coronary CT angiography (CCTA) scans for plaque quantification.
Catch up on the most-well viewed radiology content in October 2025.
